MEER APOTHEEK: what changed
MEER APOTHEEK
Largest movements
- Stocks and contracts -€46,918
down €46,918 (-11.0%), from €425,901 to €378,983
- Tangible fixed assets -€34,291
down €34,291 (-34.2%), from €100,361 to €66,070
of which Plant, machinery and equipment: -€21,362
- Cash -€16,440
down €16,440 (-13.0%), from €126,484 to €110,045
mainly Trade debts (-€49,967) and Other debts (-€31,823)
- Receivables within one year -€12,240
down €12,240 (-8.1%), from €150,753 to €138,513
of which Trade receivables: -€18,316
- Trade debts -€49,967
down €49,967 (-23.3%), from €214,451 to €164,484
- Other debts -€31,823
down €31,823 (-24.3%), from €130,947 to €99,124
- Debts after one year -€21,574
down €21,574 (-24.0%), from €90,053 to €68,480
- Gross operating margin -€101,531
down €101,531 (-37.6%), from €269,884 to €168,352
- Taxes -€9,297
down €9,297 (-82.8%), from €11,232 to €1,934
- Depreciation +€4,868
up €4,868 (+16.1%), from €30,327 to €35,196
- Financial charges -€4,781
down €4,781 (-49.3%), from €9,702 to €4,921
- Staff costs +€3,103
up €3,103 (+2.5%), from €121,937 to €125,040
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €816,371 | €705,802 | -€110,569 | -13.5% |
| Fixed assets | 21/28 | €100,361 | €66,070 | -€34,291 | -34.2% |
| Tangible fixed assets | 22/27 | €100,361 | €66,070 | -€34,291 | -34.2% |
| Plant, machinery and equipment | 23 | €87,432 | €66,070 | -€21,362 | -24.4% |
| Leasing and similar rights | 25 | €12,929 | €0 | -€12,929 | -100% |
| Current assets | 29/58 | €716,010 | €639,732 | -€76,278 | -10.7% |
| Stocks and contracts in progress | 3 | €425,901 | €378,983 | -€46,918 | -11.0% |
| Stocks | 30/36 | €425,901 | €378,983 | -€46,918 | -11.0% |
| Amounts receivable within one year | 40/41 | €150,753 | €138,513 | -€12,240 | -8.1% |
| Trade receivables | 40 | €149,242 | €130,926 | -€18,316 | -12.3% |
| Other amounts receivable | 41 | €1,510 | €7,587 | +€6,076 | +402% |
| Cash at bank and in hand | 54/58 | €126,484 | €110,045 | -€16,440 | -13.0% |
| Deferred charges and accrued income | 490/1 | €12,872 | €12,192 | -€680 | -5.3% |
| Total equity and liabilities | 10/49 | €816,371 | €705,802 | -€110,569 | -13.5% |
| Equity | 10/15 | €325,559 | €327,750 | +€2,192 | +0.7% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €306,860 | €309,052 | +€2,192 | +0.7% |
| Distributable reserves | 133 | €306,860 | €309,052 | +€2,192 | +0.7% |
| Profit (loss) carried forward | 14 | €107 | €107 | = | 0.0% |
| Amounts payable | 17/49 | €490,812 | €378,052 | -€112,760 | -23.0% |
| Amounts payable after more than one year | 17 | €90,053 | €68,480 | -€21,574 | -24.0% |
| Financial debts | 170/4 | €90,053 | €68,480 | -€21,574 | -24.0% |
| Amounts payable within one year | 42/48 | €397,046 | €309,572 | -€87,474 | -22.0% |
| Current portion of amounts payable after more than one year | 42 | €22,633 | €21,472 | -€1,161 | -5.1% |
| Trade debts | 44 | €214,451 | €164,484 | -€49,967 | -23.3% |
| Suppliers | 440/4 | €214,451 | €164,484 | -€49,967 | -23.3% |
| Taxes, remuneration and social security | 45 | €29,014 | €24,491 | -€4,523 | -15.6% |
| Taxes | 450/3 | €5,134 | €1,205 | -€3,929 | -76.5% |
| Remuneration and social security | 454/9 | €23,880 | €23,286 | -€594 | -2.5% |
| Other amounts payable | 47/48 | €130,947 | €99,124 | -€31,823 | -24.3% |
| Accrued charges and deferred income | 492/3 | €3,713 | €0 | -€3,713 | -100% |
| Remuneration, social security and pensions | 62 | €121,937 | €125,040 | +€3,103 | +2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,327 | €35,196 | +€4,868 | +16.1% |
| Other operating charges | 640/8 | €505 | €520 | +€14 | +2.8% |
| Gross operating margin | 9900 | €269,884 | €168,352 | -€101,531 | -37.6% |
| Operating profit (loss) | 9901 | €117,114 | €7,597 | -€109,517 | -93.5% |
| Financial income | 75/76B | €2,825 | €1,450 | -€1,374 | -48.7% |
| Recurring financial income | 75 | €2,825 | €1,450 | -€1,374 | -48.7% |
| Financial charges | 65/66B | €9,702 | €4,921 | -€4,781 | -49.3% |
| Recurring financial charges | 65 | €9,702 | €4,921 | -€4,781 | -49.3% |
| Profit (loss) for the period before taxes | 9903 | €110,237 | €4,126 | -€106,111 | -96.3% |
| Income taxes | 67/77 | €11,232 | €1,934 | -€9,297 | -82.8% |
| Profit (loss) for the period | 9904 | €99,005 | €2,192 | -€96,813 | -97.8% |
| Profit (loss) for the period to be appropriated | 9905 | €99,005 | €2,192 | -€96,813 | -97.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.